secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001437749-22-028437
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.02, 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Patheon terminates manufacturing agreement with AcelRx; effective May 31, 2024
------------------------------------------------------------------------------

- Patheon provided notice on Nov 29, 2022 to terminate the MSA, originally dated Dec 12, 2012.
- MSA termination effective May 31, 2024; Patheon to continue supplying product until then.
- Capital Equipment Agreement between parties likewise terminates upon MSA termination.
- AcelRx expects to discuss a transition plan with Patheon in the near future.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774922028437/0001437749-22-028437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774922028437/acrx20221204_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer